 |
|
|
| |
Open Label Study to Evaluate Safety, Tolerability, and Efficacy of Telaprevir (TVR) in Combination with Sofosbuvir (SOF) in Treatment-naïve Patients with Genotype 1 Hepatitis C Virus Infection
|
| |
| |
Reported by Jules Levin
NY AASLD/EASL HCV Special Symposium Sept 2014
Morelli G1, Firpi R1, Horne P1, Peter J1, Akushevich L2, Vainorius M2, George S3, Kieffer T3, Garg V3, Fried MW2, Nelson DR1
University of Florida1, University of North Carolina2, and Vertex Pharmaceuticals Inc3.
|
| |
|
|
|
|
|
